These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 26755886)

  • 21. [Efficacy of transarterial chemolipiodolization with or without 3-dimensional conformal radiotherapy for huge HCC with portal vein tumor thrombosis].
    You CR; Jang JW; Kang SH; Bae SH; Choi JY; Yoon SK; Choi IB; Lee DH; Chun HJ; Choi BG
    Korean J Hepatol; 2007 Sep; 13(3):378-86. PubMed ID: 17898554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
    Kodama K; Kawaoka T; Aikata H; Uchikawa S; Nishida Y; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Kimura T; Nagata Y; Chayama K
    Oncology; 2018; 94(4):215-222. PubMed ID: 29428943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J; Zheng JS; Sun B; Lu N
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis.
    Leng JJ; Xu YZ; Dong JH
    ANZ J Surg; 2016 Oct; 86(10):816-820. PubMed ID: 25088384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH; Chen LH
    Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anlotinib followed by transarterial chemoembolization and radiofrequency ablation is a safe and effective initial treatment for hepatocellular carcinoma patients with portal vein tumor thrombus: A retrospective case series study.
    Wang J; Li X; Wang F; Shi D; Zhang J
    J Cancer Res Ther; 2021 Jul; 17(3):619-624. PubMed ID: 34269290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study.
    Luo J; Guo RP; Lai EC; Zhang YJ; Lau WY; Chen MS; Shi M
    Ann Surg Oncol; 2011 Feb; 18(2):413-20. PubMed ID: 20839057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis.
    Gramenzi A; Golfieri R; Mosconi C; Cappelli A; Granito A; Cucchetti A; Marinelli S; Pettinato C; Erroi V; Fiumana S; Bolondi L; Bernardi M; Trevisani F;
    Liver Int; 2015 Mar; 35(3):1036-47. PubMed ID: 24750853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
    Han K; Kim JH
    World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
    Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
    Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016.
    Chan SL; Chong CC; Chan AW; Poon DM; Chok KS
    World J Gastroenterol; 2016 Aug; 22(32):7289-300. PubMed ID: 27621575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study.
    Mähringer-Kunz A; Steinle V; Kloeckner R; Schotten S; Hahn F; Schmidtmann I; Hinrichs JB; Düber C; Galle PR; Lang H; Weinmann A
    PLoS One; 2021; 16(5):e0249426. PubMed ID: 33961627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
    Zhang X; Wang K; Wang M; Yang G; Ye X; Wu M; Cheng S
    Oncotarget; 2017 Apr; 8(17):29416-29427. PubMed ID: 28177886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis.
    Wang JC; Xia AL; Xu Y; Lu XJ
    J Cell Physiol; 2019 Feb; 234(2):1062-1070. PubMed ID: 30256409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in treatment strategies for hepatocellular carcinoma with portal vein cancer thrombus.
    Tan ZB; Zhang J
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8119-8134. PubMed ID: 37750640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of complete remission of advanced hepatocellular carcinoma with type III portal vein tumor thrombosis treated using transarterial chemoembolization with microspheres and radiation therapy.
    Fukushima D; Imai S; Nishino N; Hamada K; Horikawa Y; Shiwa Y; Nishida S; Koyanagi R; Wada H; Sakuma H
    Clin J Gastroenterol; 2020 Oct; 13(5):847-854. PubMed ID: 32350739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis.
    Nakazawa T; Hidaka H; Shibuya A; Okuwaki Y; Tanaka Y; Takada J; Minamino T; Watanabe M; Kokubu S; Koizumi W
    BMC Gastroenterol; 2014 May; 14():84. PubMed ID: 24886354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endovascular implantation of iodine-125 seeds strand and portal vein stenting followed by transcatheter arterial chemoembolization combined therapy with sorafenib for hepatocellular carcinoma with main portal vein tumor thrombus].
    Li WW; Dai ZY; Wan HG; Yao LZ; Zhu J; Li CL; Wang XJ; Pan J; Chen LZ
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(23):1838-42. PubMed ID: 27356794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination Chemotherapy Using Sorafenib and Hepatic Arterial Infusion with a Fine-Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis--A Case Report].
    Tsukamoto T; Kanazawa A; Shimizu S; Murata A; Sakae M; Kurihara S; Tashima T; Deguchi S; Nakai T; Kawasaki Y; Kioka K
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1878-80. PubMed ID: 26805203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.